Medlander's August 4 Investor Relations Activity Record Shows: With the increasingly severe global aging phenomenon, the continuous improvement in residents' economic living standards, and the gradual enhancement of health awareness, the number of Chinese women voluntarily undergoing screening and treatment for PFD is increasing year by year. The population covered by related medical services shows a significant upward trend. Early, timely, and correct treatment of PFD patients has avoided surgical expenses and the use of medical consumables, saving costs for families and society while preventing and treating female PFD at its source. Currently, the prevention and treatment of PFD have gradually expanded from secondary and tertiary hospitals to grassroots obstetrics and gynecology departments. The clinical demand for pelvic floor rehabilitation medical devices is continuously being released, promoting the rapid development of the pelvic floor rehabilitation industry.
The pelvic floor ultrasound imaging equipment based on AI, independently developed by the company, belongs to specialized ultrasound imaging, specifically serving clinical departments such as obstetrics and gynecology and pelvic floor centers to enhance the accuracy and convenience of pelvic floor auxiliary diagnosis. This indicates that the automation system for pelvic floor diagnosis and treatment will reach a new level, integrating diagnostic indicators with pelvic floor structural visualization and completing the evolution from product solutions to scenario-based solutions.